These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14614019)

  • 21. Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma.
    Zanetto A; Campello E; Spiezia L; Burra P; Simioni P; Russo FP
    Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30453547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perioperative thrombotic complications associated with pediatric liver transplantation: a UNOS database evaluation.
    Bezinover D; Deacutis MF; Dalal PG; Moore RP; Stine JG; Wang M; Reeder E; Hollenbeak CS; Saner FH; Riley TR; Janicki PK
    HPB (Oxford); 2019 Mar; 21(3):370-378. PubMed ID: 30266497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative analysis of tumor-associated vascular changes following TACE alone or in combination with sorafenib treatment in HCC: A retrospective study.
    Chen L; Zheng Y; Zhang H; Pan H; Liu Q; Zhou X; Wei W; Liu Y; Zhen M; Wang J; Zhou J; Zhao Y
    Oncol Lett; 2018 Sep; 16(3):3690-3698. PubMed ID: 30127979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor microenvironment mediated by suppression of autophagic flux drives liver malignancy.
    Chen KD; Lin CC; Tsai MC; Huang KT; Chiu KW
    Biomed J; 2018 Jun; 41(3):163-168. PubMed ID: 30080656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signaling Pathways as Potential Therapeutic Targets in Hepatocarcinogenesis.
    Yılmaz Y; Güneş A; Topel H; Atabey N
    J Gastrointest Cancer; 2017 Sep; 48(3):225-237. PubMed ID: 28819741
    [No Abstract]   [Full Text] [Related]  

  • 26. Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signaling.
    Tsai MC; Chen KD; Wang CC; Huang KT; Wu CH; Kuo IY; Chen LY; Hu TH; Goto S; Nakano T; Dorling A; McVey JH; Chen CL; Lin CC
    Cell Death Discov; 2015; 1():15051. PubMed ID: 27551480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune conditions are associated with perioperative thrombotic complications in liver transplant recipients: A UNOS database analysis.
    Bezinover D; Iskandarani K; Chinchilli V; McQuillan P; Saner F; Kadry Z; Riley TR; Janicki PK
    BMC Anesthesiol; 2016 May; 16(1):26. PubMed ID: 27207434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of epirubicin-incorporating micelles tagged with anti-tissue factor antibody clone with no anticoagulant effect.
    Sugaya A; Hyodo I; Koga Y; Yamamoto Y; Takashima H; Sato R; Tsumura R; Furuya F; Yasunaga M; Harada M; Tanaka R; Matsumura Y
    Cancer Sci; 2016 Mar; 107(3):335-40. PubMed ID: 26676840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiangiogenic and antiproliferative effects of black pomegranate peel extract on melanoma cell line.
    Dana N; Javanmard ShH; Rafiee L
    Res Pharm Sci; 2015; 10(2):117-24. PubMed ID: 26487888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imaging.
    Bouattour M; Payancé A; Wassermann J
    World J Hepatol; 2015 Sep; 7(20):2245-63. PubMed ID: 26380650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interconnections between autophagy and the coagulation cascade in hepatocellular carcinoma.
    Chen KD; Wang CC; Tsai MC; Wu CH; Yang HJ; Chen LY; Nakano T; Goto S; Huang KT; Hu TH; Chen CL; Lin CC
    Cell Death Dis; 2014 May; 5(5):e1244. PubMed ID: 24853422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Untreated stage IV melanoma patients exhibit abnormal monocyte phenotypes and decreased functional capacity.
    Chavan R; Salvador D; Gustafson MP; Dietz AB; Nevala W; Markovic SN
    Cancer Immunol Res; 2014 Mar; 2(3):241-8. PubMed ID: 24778320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complex IV subunit 1 defect predicts postoperative survival in hepatocellular carcinoma.
    LE PH; Huang SC; Lim SN; Chou CH; Yeh TS; Chen TC; Yen TH; Su MY; Chiu CT; Yeh CT; Lin WR
    Oncol Lett; 2014 May; 7(5):1430-1438. PubMed ID: 24765151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety.
    Welker MW; Trojan J
    Cancer Manag Res; 2013 Oct; 5():337-47. PubMed ID: 24204170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of blood coagulation in cancer: implications for tumour progression.
    Lima LG; Monteiro RQ
    Biosci Rep; 2013 Sep; 33(5):. PubMed ID: 23889169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with Tie2-siRNA in combination with carboplatin suppresses the growth of Ishikawa human endometrial carcinoma cell xenografts
    Guo F; Xun Q; Zhou H
    Oncol Lett; 2013 Jun; 5(6):1777-1782. PubMed ID: 23833640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of small interfering RNA-targeting tissue factor on an in vitro model of neovascularization.
    Peng W; Yu Y; Li T; Zhu Y; Chen H
    Mol Vis; 2013; 19():1296-303. PubMed ID: 23805036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulating surgical oncotaxis to improve the outcomes in cancer patients.
    Hirai T; Matsumoto H; Kubota H; Yamaguchi Y
    Surg Today; 2014 May; 44(5):804-11. PubMed ID: 23736890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictions.
    Finley SD; Popel AS
    J Natl Cancer Inst; 2013 Jun; 105(11):802-11. PubMed ID: 23670728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of serum vascular endothelial growth factor on prognosis in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization.
    Guo JH; Zhu X; Li XT; Yang RJ
    Chin J Cancer Res; 2012 Mar; 24(1):36-43. PubMed ID: 23359473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.